BlackRock Institutional Trust’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$4.99M Hold
398,499
﹤0.01% 2726
2016
Q3
$5.52M Buy
398,499
+45,793
+13% +$634K ﹤0.01% 2647
2016
Q2
$3.49M Buy
352,706
+21,756
+7% +$215K ﹤0.01% 2829
2016
Q1
$5.6M Buy
330,950
+4,471
+1% +$75.6K ﹤0.01% 2587
2015
Q4
$7.27M Buy
326,479
+6,307
+2% +$140K ﹤0.01% 2515
2015
Q3
$7.55M Buy
320,172
+15,752
+5% +$372K ﹤0.01% 2474
2015
Q2
$24.9M Buy
304,420
+99,232
+48% +$8.11M ﹤0.01% 1770
2015
Q1
$19M Buy
205,188
+118,358
+136% +$11M ﹤0.01% 1975
2014
Q4
$3.51M Buy
86,830
+16,481
+23% +$666K ﹤0.01% 2869
2014
Q3
$1.72M Sell
70,349
-3,176
-4% -$77.7K ﹤0.01% 3134
2014
Q2
$1.17M Sell
73,525
-1,040
-1% -$16.5K ﹤0.01% 3383
2014
Q1
$1.13M Sell
74,565
-18,628
-20% -$282K ﹤0.01% 3369
2013
Q4
$1.28M Buy
93,193
+13,420
+17% +$184K ﹤0.01% 3319
2013
Q3
$1.51M Buy
+79,773
New +$1.51M ﹤0.01% 3242